BIOA vs GLUE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

BIOA

39.7
AI Score
VS
BIOA Wins

GLUE

39.4
AI Score

Investment Advisor Scores

BIOA

40score
Recommendation
AVOID NEW MONEY

GLUE

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOA GLUE Winner
Forward P/E 0 10.02 Tie
PEG Ratio 0 0 Tie
Revenue Growth 1.6% -61.3% BIOA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.7/100 39.4/100 BIOA
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

BIOA 1M: -32.1% · 3M: -73.4% GLUE 1M: -26.2% · 3M: -54.8%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.9%), weak momentum, RSI 25

RSI (14): 25.1 · Price: $6.61

GLUE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.7%), weak momentum, RSI 24

RSI (14): 23.7 · Price: $10.50

Fundamentals Snapshot

Metric BIOA GLUE
Market Cap — —
Forward P/E -2.7 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.6%
Gross Margin -7.5% -4.7%
Operating Margin -12.0% -5.5%
EPS -2.29 -1.75
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.